Thrombolytic therapy for acute ischemic stroke

Research output: Contribution to journalArticle

Abstract

The treatment of acute stroke changed dramatically since the publication of the NINDS trail for IV rt-PA for acute stroke. While this was not the first trial, it was the first positive trial. Subsequently there has been an explosion in acute treatment modalities since the NINDS trial showed that acute stroke treatment is feasible. The following chapter reviews the thrombolysis trials, the inclusion and exclusion criteria of intravenous and intra-arterial use of pharmacologic and mechanical thrombolysis in acute ischemic stroke. Also discussed are the new pharmacotherapies and mechanical devices that will hopefully expand the treatment window and make thrombolysis safer and more effective.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalJournal of the Neurological Sciences
Volume261
Issue number1-2
DOIs
StatePublished - Oct 15 2007

Fingerprint

Thrombolytic Therapy
Stroke
National Institute of Neurological Disorders and Stroke
Mechanical Thrombolysis
Explosions
Therapeutics
Publications
Drug Therapy
Equipment and Supplies

Keywords

  • Acute ischemic stroke
  • Intra-arterial thrombolysis
  • Revascularization
  • rt-PA
  • Thrombolytic therapy

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Thrombolytic therapy for acute ischemic stroke. / Blakeley, Jaishri; Llinas, Rafael H.

In: Journal of the Neurological Sciences, Vol. 261, No. 1-2, 15.10.2007, p. 55-62.

Research output: Contribution to journalArticle

@article{62dad42440dd4193a43b9f08d2fce410,
title = "Thrombolytic therapy for acute ischemic stroke",
abstract = "The treatment of acute stroke changed dramatically since the publication of the NINDS trail for IV rt-PA for acute stroke. While this was not the first trial, it was the first positive trial. Subsequently there has been an explosion in acute treatment modalities since the NINDS trial showed that acute stroke treatment is feasible. The following chapter reviews the thrombolysis trials, the inclusion and exclusion criteria of intravenous and intra-arterial use of pharmacologic and mechanical thrombolysis in acute ischemic stroke. Also discussed are the new pharmacotherapies and mechanical devices that will hopefully expand the treatment window and make thrombolysis safer and more effective.",
keywords = "Acute ischemic stroke, Intra-arterial thrombolysis, Revascularization, rt-PA, Thrombolytic therapy",
author = "Jaishri Blakeley and Llinas, {Rafael H}",
year = "2007",
month = "10",
day = "15",
doi = "10.1016/j.jns.2007.04.031",
language = "English (US)",
volume = "261",
pages = "55--62",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Thrombolytic therapy for acute ischemic stroke

AU - Blakeley, Jaishri

AU - Llinas, Rafael H

PY - 2007/10/15

Y1 - 2007/10/15

N2 - The treatment of acute stroke changed dramatically since the publication of the NINDS trail for IV rt-PA for acute stroke. While this was not the first trial, it was the first positive trial. Subsequently there has been an explosion in acute treatment modalities since the NINDS trial showed that acute stroke treatment is feasible. The following chapter reviews the thrombolysis trials, the inclusion and exclusion criteria of intravenous and intra-arterial use of pharmacologic and mechanical thrombolysis in acute ischemic stroke. Also discussed are the new pharmacotherapies and mechanical devices that will hopefully expand the treatment window and make thrombolysis safer and more effective.

AB - The treatment of acute stroke changed dramatically since the publication of the NINDS trail for IV rt-PA for acute stroke. While this was not the first trial, it was the first positive trial. Subsequently there has been an explosion in acute treatment modalities since the NINDS trial showed that acute stroke treatment is feasible. The following chapter reviews the thrombolysis trials, the inclusion and exclusion criteria of intravenous and intra-arterial use of pharmacologic and mechanical thrombolysis in acute ischemic stroke. Also discussed are the new pharmacotherapies and mechanical devices that will hopefully expand the treatment window and make thrombolysis safer and more effective.

KW - Acute ischemic stroke

KW - Intra-arterial thrombolysis

KW - Revascularization

KW - rt-PA

KW - Thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=34548179532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548179532&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.04.031

DO - 10.1016/j.jns.2007.04.031

M3 - Article

C2 - 17618652

AN - SCOPUS:34548179532

VL - 261

SP - 55

EP - 62

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -